atrasentan has been researched along with Hemolysis, Elevated Liver Enzymes, Lowered Platelets in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowles, T; Gibbens, J; Morris, R; Spencer, SK; Wallace, K | 1 |
| Harris, A; Kyle, PB; Morris, R; Owens, MY; Spencer, SK; Wallace, K; Williams, JM | 1 |
2 other study(ies) available for atrasentan and Hemolysis, Elevated Liver Enzymes, Lowered Platelets
| Article | Year |
|---|---|
Dysregulation of the Fas/FasL system in an experimental animal model of HELLP syndrome.
Topics: Animals; Atrasentan; Disease Models, Animal; Endoglin; Endothelin A Receptor Antagonists; Fas Ligand Protein; fas Receptor; Female; Gene Expression Regulation; HELLP Syndrome; Liver; Placenta; Pregnancy; Pyrrolidines; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Vascular Endothelial Growth Factor Receptor-1 | 2017 |
Hypertension in an Animal Model of HELLP Syndrome is Associated With Activation of Endothelin 1.
Topics: Animals; Atrasentan; Disease Models, Animal; Endoglin; Endothelin-1; Female; HELLP Syndrome; Hypertension; Placenta; Pregnancy; Pyrrolidines; Rats; Vascular Endothelial Growth Factor Receptor-1 | 2016 |